strong
evid
interferoninduc
transmembran
protein
viru
restrict
factor
mediat
cellular
resist
influenza
virus
virus
enter
cell
via
acid
import
influenza
viru
infect
determin
everitt
et
show
sever
influenza
viru
infect
greatli
increas
knockout
mice
compar
wildtyp
anim
human
rare
snp
allel
truncat
protein
lead
reduc
restrict
viru
replic
northern
european
patient
infect
hospit
season
influenza
pandem
influenza
viru
increas
homozygos
minor
c
allel
snp
versu
first
direct
evid
host
genet
influenc
influenza
sever
human
howev
rariti
suscept
allel
minor
allel
peopl
northern
european
descent
overal
effect
sever
pandem
season
influenza
viru
popul
like
small
howev
frequenc
suscept
allel
known
much
higher
han
chines
minor
allel
examin
influenc
polymorph
sever
influenza
viru
infect
chines
patient
found
strike
high
frequenc
cc
genotyp
among
patient
china
infect
pandem
viru
sever
ill
compar
mild
infect
healthi
han
chines
impli
presenc
variant
gene
influenc
diseas
sever
rather
suscept
infect
furthermor
use
statist
analysi
tool
estim
patient
cc
genotyp
sixfold
greater
risk
sever
infect
compar
ct
tt
genotyp
much
higher
level
cc
allel
popul
level
han
chines
compar
caucasian
may
place
chines
higher
risk
develop
sever
ill
upon
influenza
viru
infect
pandem
hospit
china
admit
patient
sever
infect
also
unusu
patient
mild
infect
normal
circumst
would
requir
hospit
opendoor
polici
provid
uniqu
opportun
captur
rel
unselect
group
patient
diverg
outcom
observ
manag
similar
clinic
condit
cohort
patient
fulfil
criteria
inclus
influenza
infect
confirm
viral
genom
pcr
assay
abl
give
inform
consent
exclus
use
corticosteroid
immunosuppress
month
sampl
coexist
ill
pregnanc
posit
bacteri
cultur
respiratori
tract
secretionssputum
blood
point
hospit
admiss
blood
obtain
day
admiss
progress
patient
observ
throughout
durat
hospit
stay
point
discharg
patient
divid
mild
sever
diseas
perus
clinic
data
entir
cours
stay
mild
diseas
defin
report
symptom
fever
cough
headach
lethargi
whose
circul
leukocyt
profil
total
leukocyt
lymphocyt
neutrophil
normal
throughout
hospit
stay
patient
sever
diseas
report
symptom
describ
deterior
develop
pneumon
consolid
andor
bilater
infiltr
chest
radiograph
without
respiratori
failur
defin
mm
hg
respiratori
failur
dissemin
intravascular
coagulopathi
renal
failur
patient
patient
sever
group
use
oseltamivir
patient
mild
group
given
oseltamivir
patient
develop
pleural
effus
empyema
six
patient
mechan
ventil
among
thirteen
sever
infect
patient
die
demograph
data
shown
tabl
sequenc
base
pair
locu
encompass
snp
infect
individu
carri
cc
genotyp
higher
frequenc
han
chines
genom
sequenc
databas
cc
genotyp
tabl
fig
b
stratifi
hospit
patient
mild
sever
base
clinic
assess
tabl
mildli
ill
individu
significantli
differ
allel
frequenc
compar
han
chines
popul
sever
ill
patient
significantli
differ
allel
frequenc
compar
mild
case
compar
gener
han
chines
popul
significantli
higher
frequenc
homozyg
cc
genotyp
found
patient
develop
sever
ill
tabl
fig
c
ten
thirteen
patient
die
carri
cc
genotyp
analys
associ
sever
infect
compar
mildli
infect
individu
assum
differ
genet
model
tabl
could
explicitli
assess
whether
one
domin
two
copi
recess
c
allel
increas
risk
sever
infect
well
whether
risk
increas
signific
assum
multipl
rfold
increas
ct
cc
genotyp
addit
model
rfold
increas
ct
cc
genotyp
model
apart
domin
model
show
signific
associ
sever
infect
recess
model
largest
odd
ratio
particular
multipl
model
carrier
c
allel
show
threefold
increas
risk
sever
infect
compar
carrier
allel
multipl
model
odd
confid
interv
recess
model
homozygot
c
allel
estim
larger
sixfold
greater
risk
sever
infect
compar
heterozygot
homozygot
allel
recess
model
odd
confid
interv
togeth
analys
suggest
cc
variant
increas
chanc
initi
viru
infect
associ
sever
ill
although
larger
studi
includ
anoth
popul
requir
prove
definit
cytokin
monocyt
chemotact
elev
sever
viral
infect
level
rais
lung
knockout
mice
influenza
viru
group
patient
genotyp
found
significantli
elev
serum
level
patient
cc
genotyp
compar
patient
ct
tt
genotyp
fig
also
found
higher
level
influenza
antibodi
patient
cc
genotyp
fig
data
indic
cc
genotyp
associ
overt
immun
respons
possibl
due
higher
viral
antigen
load
observ
signific
differ
tcell
respons
measur
interferongamma
elispot
assay
peptid
span
whole
viru
proteom
patient
without
cc
genotyp
fig
data
show
associ
diseas
sever
follow
influenza
viru
infect
chines
popul
restrict
replic
influenza
viru
infect
human
mice
howev
cc
homozygot
like
suffer
sever
respiratori
patholog
uk
caucasian
han
chines
larger
scale
studi
urgent
requir
determin
whether
genotyp
han
chines
asian
patient
infect
influenza
viru
predict
might
progress
sever
diseas
earli
infect
might
possibl
improv
prognosi
earli
intensif
treatment
addit
genotyp
consid
select
patient
clinic
trial
studi
influenza
viru
infect
especi
involv
viru
challeng
low
pathogen
viru
snp
type
china
cost
us
per
sampl
could
done
larg
hospit
laboratori
effect
depend
influenza
viru
subtyp
restrict
influenza
b
studi
show
effect
sever
low
pathogen
influenza
viru
human
pathogen
viru
avian
influenza
viru
high
fatal
rate
possibl
cc
genotyp
could
enhanc
diseas
virul
viru
overrid
usual
protect
effect
ct
tt
genotyp
need
studi
futur
studi
also
ask
whether
diseas
cours
differ
sever
infect
patient
cc
genotyp
ct
tt
genotyp
intrigu
cc
rare
northern
european
common
asian
popul
mani
viral
infect
restrict
vitro
includ
sever
acut
respiratori
syndrom
sar
coronaviru
dengu
viru
west
nile
high
popul
allel
frequenc
may
influenc
complex
viru
exposur
estim
mani
individu
would
develop
sever
infect
specif
due
cc
genotyp
given
populationattribut
risk
par
larg
depend
frequenc
risk
genotyp
popul
risk
genotyp
occur
high
frequenc
chines
popul
effect
translat
larg
par
account
sever
infect
much
larger
correspond
par
northern
european
impli
incid
sever
influenza
infect
might
higher
chines
northern
european
explor
futur
epidemiolog
studi
conclus
data
clearli
extend
earlier
observ
european
cohort
genotyp
significantli
associ
influenza
sever
associ
primarili
sever
diseas
rather
suscept
infect
although
larger
studi
requir
prove
specif
associ
may
import
role
viru
replic
dissemin
follow
initi
infect
much
higher
level
cc
genotyp
han
chines
popul
compar
caucasian
may
place
chines
higher
risk
develop
sever
ill
upon
influenza
infect
known
whether
sever
infect
influenza
viru
like
spread
infect
case
high
frequenc
c
allel
asian
popul
may
influenc
epidemiolog
influenza
patient
recruit
beij
hospit
beij
june
januari
studi
approv
institut
review
board
beij
hospit
written
inform
consent
obtain
patient
genom
dna
extract
peripher
blood
mononuclear
cell
use
puregen
dna
isol
kit
gentra
system
minneapoli
mn
usa
region
encompass
human
sequenc
amplifi
polymeras
chain
reaction
amplif
perform
use
follow
forward
revers
primer
beij
institut
genom
bgi
shenzhen
china
pcr
product
purifi
sequenc
appli
biosystem
dna
analys
gatc
biotech
singlenucleotid
polymorph
identifi
use
chroma
technelysium
pti
ltd
bgi
shenzhen
china
edtasepar
serum
store
analysi
analys
use
human
cytokin
multiplex
assay
biorad
usa
luminex
multianalyt
profil
technolog
biorad
usa
accord
manufactur
instruct
describ
brief
serum
sampl
dilut
sampl
diluent
standard
reconstitut
standard
diluent
standard
sampl
incub
magnet
bead
plate
min
room
temperatur
detect
antibodi
ad
well
incub
room
temperatur
min
streptavidinp
use
fluorochrom
antibodi
detect
use
bioplex
manag
softwar
version
standard
luminex
mainten
procedur
perform
bioplex
bead
use
calibr
system
antibodi
titr
serum
sampl
determin
haemagglutin
inhibit
assay
describ
brief
serum
sampl
treat
receptor
destroy
enzym
vibrio
cholera
dilut
one
part
serum
three
part
enzym
incub
overnight
water
bath
heatinactiv
min
accord
world
health
organ
standard
procedur
serum
sampl
dilut
serial
twofold
dilut
mix
suspens
chicken
red
blood
cell
four
hemagglutin
unit
local
isol
viru
strain
viru
total
peptid
overlap
aminoacid
residu
span
full
proteom
epidem
influenza
viru
synthes
pepscreen
sigmaaldrich
use
sequenc
strain
six
overlap
peptid
pool
repres
eight
intern
protein
gener
h
elispot
assay
perform
use
cryopreserv
peripher
blood
mononuclear
cell
pbmc
describ
two
lakh
fifti
thousand
pbmc
use
elispot
well
final
volum
end
concentr
peptid
well
test
peptid
pool
test
individu
peptid
neg
posit
control
pbmc
incub
media
alon
phytohemagglutinin
wellcom
respect
spot
form
unit
sfu
count
use
autom
elispot
reader
aid
respons
consid
posit
number
sfu
per
well
greater
three
time
averag
neg
control
valu
given
assay
four
time
mean
neg
control
valu
obtain
peptid
pool
screen
particip
adjust
sfu
subtract
averag
neg
valu
express
sfu
per
pbmc
statist
analysi
genet
data
perform
use
rstat
librari
rstatist
associ
test
differ
genet
model
fisher
exact
test
addit
use
sinc
approxim
might
hold
small
sampl
cochranarmitag
test
trend
use
test
associ
addit
genet
model
associ
sever
infect
assess
analys
sever
infect
individu
mildli
infect
individu
latter
show
signific
differ
han
popul
genom
project
repres
better
populationmatch
group
sever
infect
sampl
odd
ratio
calcul
associ
specif
risk
allel
genotyp
reflect
rel
risk
risk
allel
given
incid
sever
infect
observ
suffici
low
par
estim
assumpt
frequenc
risk
genotyp
cc
mildli
infect
individu
reflect
genotyp
popul
frequenc
formula
use
par
calcul
par
p
p
p
repres
risk
genotyp
frequenc
popul
rr
repres
rel
risk
risk
genotyp
cc
calcul
par
northern
european
genotyp
count
hospit
patient
north
european
popul
genom
project
use
given
everitt
et
statist
analys
perform
graphpad
prism
v
graphpad
softwar
san
diego
ca
independ
sampl
ttest
use
data
normal
distribut
evalu
test
compar
haemagglutin
inhibit
level
age
white
blood
cell
neutrophil
count
mild
sever
diseas
test
use
data
normal
distribut
chisquar
test
employ
analys
differ
gender
comorbid
pneumonia
respiratori
failur
mild
sever
group
cite
articl
yonghong
zhang
et
al
interferoninduc
transmembran
genet
variant
associ
sever
influenza
chines
individu
nat
commun
doi
